- Home
- FDMT vs STKE Comparison
FDMT vs STKE Comparison
Compare FDMT & STKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- STKE
- Stock Information
- Founded
- FDMT 2013
- STKE 2002
- Country
- FDMT United States
- STKE
- Employees
- FDMT N/A
- STKE N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- STKE
- Sector
- FDMT Health Care
- STKE
- Exchange
- FDMT Nasdaq
- STKE Nasdaq
- Market Cap
- FDMT 192.2M
- STKE 162.8M
- IPO Year
- FDMT 2020
- STKE N/A
- Fundamental
- Price
- FDMT $6.81
- STKE N/A
- Analyst Decision
- FDMT Buy
- STKE
- Analyst Count
- FDMT 9
- STKE 0
- Target Price
- FDMT $30.63
- STKE N/A
- AVG Volume (30 Days)
- FDMT 643.1K
- STKE 463.2K
- Earning Date
- FDMT 11-12-2025
- STKE 01-29-2026
- Dividend Yield
- FDMT N/A
- STKE N/A
- EPS Growth
- FDMT N/A
- STKE N/A
- EPS
- FDMT N/A
- STKE N/A
- Revenue
- FDMT $33,000.00
- STKE $14,342,517.00
- Revenue This Year
- FDMT $8,572.97
- STKE N/A
- Revenue Next Year
- FDMT N/A
- STKE N/A
- P/E Ratio
- FDMT N/A
- STKE N/A
- Revenue Growth
- FDMT N/A
- STKE N/A
- 52 Week Low
- FDMT $2.24
- STKE $0.65
- 52 Week High
- FDMT $17.41
- STKE $34.32
- Technical
- Relative Strength Index (RSI)
- FDMT 56.27
- STKE N/A
- Support Level
- FDMT $6.09
- STKE N/A
- Resistance Level
- FDMT $7.21
- STKE N/A
- Average True Range (ATR)
- FDMT 0.44
- STKE 0.00
- MACD
- FDMT -0.04
- STKE 0.00
- Stochastic Oscillator
- FDMT 58.74
- STKE 0.00
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.